Mycobacterium tuberculosis (M. tuberculosis) is a highly pathogenic
intracellular pathogen that causes tuberculosis (TB),
the leading cause of mortality from single infections. Redox
homeostasis plays a very important role in the resistance of
M. tuberculosis to antibiotic damage and various environmental
stresses. The antioxidant sulforaphane (SFN) has been
reported to exhibit anticancer activity and inhibit the growth
of a variety of bacteria and fungi. Nonetheless, it remains unclear
whether SFN exhibits anti-mycobacterial activity. Our results showed that the SFN against M. tuberculosis H37Ra
exhibited bactericidal activity in a time and dose-dependent
manner. The anti-tubercular activity of SFN was significantly
correlated with bacterial reactive oxygen species (ROS) levels.
In addition, SFN promoted the bactericidal effect of macrophages
on intracellular bacteria in a dose-dependent manner,
mediated by increasing intracellular mitochondrial ROS
levels and decreasing cytoplasmic ROS levels. Taken together,
our data revealed the previously unrecognized antimicrobial
functions of SFN. Future studies focusing on the mechanism
of SFN in macrophages against M. tuberculosis are
essential for developing new host-directed therapeutic approaches
against TB.
Citations
Citations to this article as recorded by
NK-derived exosome miR-1249-3p inhibits Mycobacterium tuberculosis survival in macrophages by targeting SKOR1 Fengqian Ma, Xuan Wang, Zhanghua Qiu, Shoupeng Ding, Wenya Du, Yumei Dai, Tao Ma, Linzhi Yue, Guofu Wang, Tao Wang, Ling Geng, Lixian Wu Cytokine.2024; 175: 156481. CrossRef
Lactobacillus plantarum increase the sulforaphane formation efficiency via microbial-targeted delivery system in vivo Yunping Wang, Yiteng Zhang, Xiude Li, Liping Luo, Fangjian Ning, Tao Liu, Jinwang Li Food Bioscience.2024; 62: 105544. CrossRef
Identifying autophagy-related genes as potential targets for immunotherapy in tuberculosis Sifang Xiao, Ting Zhou, Jianhua Pan, Xiaohua Ma, Guomin Shi, Binyuan Jiang, Yan-gen Xiang International Immunopharmacology.2023; 118: 109956. CrossRef